Skip to content

Efficacy of an exercise training programme for patients with ischaemic cardiopathy

Randomised hospital-based clinical trial on the efficacy of an exercise training programme versus care as usual for adult patients with ischaemic cardiopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57634424
Enrollment
292
Registered
2010-05-27
Start date
2010-06-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischaemic cardiopathy Circulatory System Complications and ill-defined descriptions of heart disease

Interventions

Control group: Patients will receive the usual therapy of our hospital. Hospitalised patients will be instructed to do exercises to regain mobility in order to maintain and improve muscular tone and

Sponsors

Fundació Althaia (Spain) - Xarxa Assistencial Universitària de Manresa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old (either sex), autonomous and able to take decisions, who accept to participate in the study 2. Patients diagnosed with ischaemic cardiopathy admitted to the Cardiology Service at our centre 3. Patients without cognitive deficit, able to follow the cardiac rehabilitation programme 4. Patients with cardiopathy, residing in the service area of Althaia

Exclusion criteria

Exclusion criteria: 1. Patients under 18 years old 2. Patients with symptoms of cor pulmonale 3. Patients with additional diagnosis affecting prognosis of cardiac disease 4. Patients with dyspnoea caused by severe pulmonary pathology 5. Patients with cardiopathy residing outside the service area of Althaia 6. Patients who do not accept to participate in the study

Design outcomes

Primary

MeasureTime frame
1. Number of admissions for any reason during period of follow-up, measured at 15 days, 3, 6 and 12 months 2. Number of admissions with main cardiac diagnosis at discharge during period of follow-up, measured at 15 days, 3, 6 and 12 months 3. Time from first admission, measured at 15 days, 3, 6 and 12 months 4. Percentage of patients readmitted during period of follow-up, measured at 15 days, 3, 6 and 12 months 5. Total days of hospitalisation for any reason during period of follow-up, measured at 15 days, 3, 6 and 12 months 6. Total days of hospitalisation for cardiac event during period of follow-up, measured at 15 days, 3, 6 and 12 months 7. Functional status according to physical strength test, measured at 15 days and at 3 months 8. Mortality, measured at 15 days, 3, 6 and 12 months Added 21/03/2018: All outcomes are also measured at 5 years

Secondary

MeasureTime frame
Initial outcomes at time of registration: 1. Adherence to cardiac rehabilitation programme, according to attendance to follow-up visits and training sessions, measured at 15 days, 3, 6 and 12 months 2. Adherence to medication, according Haynes-Sackett test, measured at 15 days, 3, 6 and 12 months 3. Quality of life, assessed using SF-36 test at 15 days, 3 and 12 months from hospital discharge 4. Degree of patients' satisfaction with assistance received. The Ambulatory Specialised Care 2008 questionnaire of Servei Català de la Salut will be used; questions selected from the questionnaire on satisfaction of policy holders of CatSalut for services offered: Ambulatory Specialised Care 2008. This will be administered 12 months after hospital discharge As of 24/06/2010 point 3 has been amended as follows: 3. Quality of life, assessed using EuroQoL test (Spanish version) at 15 days, 3 and 12 months from hospital discharge Added 21/03/2018: 1. All-cause hospital emergency visits, assessed at 12 months and 5 years of follow-up 2. Functional status according to Caspersen & Powell classification and IPAQ questionnaire, assessed at 5 years of follow-up. 3. Return to work, assessed at 12 months and 5 years of follow-up Adherence to medication and quality of life also assessed as above at 5 years of follow-up

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026